Security Snapshot

LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) Institutional Ownership

CUSIP: 525558201

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

330

Shares (Excl. Options)

21,850,009

Price

$109.17

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, $0.01 Par Value
Symbol
LMAT on Nasdaq
Shares outstanding
22,894,297
Price per share
$111.90
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
21,850,009
Total reported value
$2,383,933,703
% of total 13F portfolios
0%
Share change
+769,604
Value change
+$95,191,097
Number of holders
330
Price from insider filings
$111.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value is tracked under CUSIP 525558201.
  • 330 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 296 to 330 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,727,874,664 to $2,383,933,703.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 330 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 525558201?
CUSIP 525558201 identifies LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% -21% $287,330,114 -$75,053,782 3,102,917 -21% BlackRock, Inc. 31 Mar 2025
Conestoga Capital Advisors, LLC 8.1% 0% $123,875,714 -$24,191,963 1,527,429 -16% Conestoga Capital Advisors 31 Dec 2025
LeMaitre George W 6.4% -15% $159,945,053 -$23,946,211 1,465,235 -13% George W. LeMaitre 31 Mar 2026
Copeland Capital Management, LLC 5.2% $91,579,548 988,980 Copeland Capital Management 31 Dec 2024

As of 31 Mar 2026, 330 institutional investors reported holding 21,850,009 shares of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT). This represents 95% of the company’s total 22,894,297 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 3,144,151 +0.38% 0.01% $343,246,976
Conestoga Capital Advisors, LLC 6.5% 1,476,813 +3.6% 3.2% $161,223,689
FIRST TRUST ADVISORS LP 4.4% 998,071 +6.2% 0.08% $108,959,411
VANGUARD CAPITAL MANAGEMENT LLC 4% 912,058 0% 0% $99,569,372
Copeland Capital Management, LLC 3.8% 870,692 -2.1% 2.1% $95,053,549
STATE STREET CORP 3.7% 855,784 +6% 0% $93,425,939
CONGRESS ASSET MANAGEMENT CO 3.6% 834,529 +14% 0.65% $91,105,488
GENEVA CAPITAL MANAGEMENT LLC 3.3% 753,992 -7.4% 1.7% $82,313,260
GEODE CAPITAL MANAGEMENT, LLC 2.9% 658,445 +4% 0% $71,893,244
VANGUARD PORTFOLIO MANAGEMENT LLC 2.5% 562,770 0% 0% $61,437,601
DIMENSIONAL FUND ADVISORS LP 2.1% 476,335 +0.1% 0.01% $51,999,066
GOLDMAN SACHS GROUP INC 1.9% 432,416 +11% 0.01% $47,206,860
MORGAN STANLEY 1.8% 407,770 -7.5% 0% $44,516,446
Invesco Ltd. 1.5% 333,977 +189% 0.01% $36,460,269
NORTHERN TRUST CORP 1.4% 312,555 -2.1% 0% $34,121,630
PRICE T ROWE ASSOCIATES INC /MD/ 1.3% 294,994 +1.7% 0% $32,206,000
TWO SIGMA INVESTMENTS, LP 1.2% 281,978 +97% 0.03% $30,783,538
ENVESTNET ASSET MANAGEMENT INC 1.2% 274,396 +8.3% 0.01% $29,955,834
ROYAL BANK OF CANADA 1.2% 272,654 -6.3% 0.01% $29,765,000
Annex Advisory Services, LLC 1.1% 250,610 +2.8% 0.51% $27,359,081
Ranger Investment Management, L.P. 1% 238,360 -37% 1.9% $26,021,761
KENNEDY CAPITAL MANAGEMENT LLC 1% 236,777 -4.5% 0.55% $25,848,945
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1% 230,718 -6.5% 0.07% $25,187,484
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.86% 197,975 +0.84% 0% $21,612,931
Driehaus Capital Management LLC 0.86% 197,225 0.16% $21,531,053

Institutional Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 21,850,009 $2,383,933,703 +$95,191,097 $109.17 330
2025 Q4 21,303,412 $1,727,874,664 +$26,162,852 $81.10 296
2025 Q3 20,972,168 $1,835,216,297 -$5,367,594 $87.51 295
2025 Q2 21,166,185 $1,758,234,218 +$2,582,636 $83.05 283
2025 Q1 21,153,493 $1,775,213,757 -$3,873,253 $83.90 286
2024 Q4 21,174,653 $1,951,282,055 +$12,366,502 $92.14 305
2024 Q3 20,982,696 $1,948,703,180 +$24,926,468 $92.89 289
2024 Q2 20,545,327 $1,690,376,215 +$24,763,593 $82.28 261
2024 Q1 20,244,067 $1,343,284,255 +$11,987,251 $66.36 242
2023 Q4 20,084,131 $1,139,986,402 +$34,733,932 $56.76 226
2023 Q3 19,480,544 $1,061,371,614 +$32,738,721 $54.48 219
2023 Q2 18,811,526 $1,264,888,648 +$4,977,677 $67.28 208
2023 Q1 18,807,566 $968,037,117 -$3,487,147 $51.47 182
2022 Q4 19,244,139 $885,480,684 -$14,154,139 $46.02 181
2022 Q3 19,520,595 $989,204,894 -$6,064,140 $50.68 183
2022 Q2 19,290,567 $878,994,108 +$29,245,065 $45.55 175
2022 Q1 18,775,944 $872,420,057 +$20,477,763 $46.47 175
2021 Q4 18,437,180 $924,595,207 -$12,946,176 $50.23 178
2021 Q3 18,624,446 $989,044,311 +$47,360,392 $53.09 190
2021 Q2 17,706,224 $1,079,385,907 -$8,059,152 $61.02 183
2021 Q1 17,933,078 $875,505,917 +$19,714,714 $48.78 176
2020 Q4 17,703,794 $717,764,963 +$18,469,809 $40.50 168
2020 Q3 17,300,958 $562,850,201 +$13,819,279 $32.53 136
2020 Q2 16,847,952 $444,929,145 +$3,973,486 $26.40 141
2020 Q1 16,762,310 $417,910,467 -$43,457,877 $24.92 137
2019 Q4 17,302,384 $621,982,984 +$53,863,207 $35.95 158
2019 Q3 15,800,432 $540,055,367 +$12,879,648 $34.18 144
2019 Q2 15,502,902 $433,878,019 +$11,708,308 $27.98 146
2019 Q1 15,094,658 $467,913,143 +$5,913,399 $31.00 147
2018 Q4 15,028,286 $355,216,642 -$34,540,813 $23.64 136
2018 Q3 15,895,861 $615,732,972 +$21,851,073 $38.74 148
2018 Q2 15,431,749 $516,844,608 +$43,655,803 $33.48 159
2018 Q1 14,110,923 $511,463,797 +$11,850,444 $36.23 152
2017 Q4 14,068,048 $448,128,778 +$17,278,492 $31.84 138
2017 Q3 13,383,046 $500,651,805 +$30,975,265 $37.42 146
2017 Q2 12,630,436 $394,298,623 +$31,152,102 $31.22 141
2017 Q1 11,695,921 $288,085,788 +$40,290,492 $24.63 113
2016 Q4 11,172,728 $283,093,485 -$284,703 $25.34 111
2016 Q3 11,333,706 $224,855,790 +$6,582,634 $19.84 107
2016 Q2 11,052,641 $157,719,884 +$5,105,142 $14.27 97
2016 Q1 10,695,804 $165,991,000 +$7,840,540 $15.52 94
2015 Q4 10,165,288 $175,379,131 +$4,609,713 $17.25 91
2015 Q3 10,165,221 $123,905,280 +$4,272,693 $12.19 84
2015 Q2 9,412,740 $113,516,982 +$9,660,518 $12.06 75
2015 Q1 8,372,852 $70,163,000 +$1,710,724 $8.38 47
2014 Q4 8,171,831 $62,515,000 +$2,242,295 $7.65 44
2014 Q3 7,399,594 $50,911,000 -$284,391 $6.88 39
2014 Q2 7,437,668 $61,512,143 +$10,678,650 $8.27 40
2014 Q1 6,132,210 $49,464,700 +$886,602 $8.07 43
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .